Re-assessing the risks of drug-induced arrhythmias during drug discovery
Drug Discovery World
AUGUST 15, 2023
Unexpected late-stage failures in drug development are, of course, the costliest. A more recent analysis has illustrated how both assay validity and reproducibility correlate across a population of simulated screening and disease models 2. Clinical Pharmacology & Therapeutics. 96(5): 549-558. Tisdale et al. Circulation.142:
130 
Let's personalize your content